findmyKOL
Clinical trialNCT04055532WithdrawnObservational

Biomarkers in Neurodegenerative Diseases

SponsorUniversity of MinnesotaEnrollment0Alzheimer Disease (AD)Amyotrophic Lateral Sclerosis (ALS)Dementia With Lewy Bodies (DLB)Frontotemporal Lobar Degeneration (FTLD)HIV Associated Neurocognitive Disorder (HAND)Mild Cognitive Impairment (MCI)+5 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The general purpose of this observational study is to examine biomarkers associated with the pathology of neurodegenerative diseases to potentially develop novel therapeutic approaches.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Minnesota

    Minneapolis, Minnesota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Oct 2019
Primary completion
1 Oct 2024
Completion
1 Oct 2025
Last update posted
12 Nov 2019
Registered enrollment
0
Registry id
NCT04055532

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.